    
|
 
|
|
|
Except for the historical information described in the presentations below, the matters set forth in such presentations, including but not limited to statements relating to our preclinical and clinical development programs and drug candidates, and any statements relating to our goals, plans, missions, expectations, beliefs, and the like, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties inherent in the development and commercialization of drugs, the risks and uncertainties associated with our technologies and those of our competitors, and other risks detailed in our quarterly report on Form 10-Q for the quarter ended September 30, 2008, as well as other subsequent filings made from time to time with the Securities and Exchange Commission, which are available at www.sec.gov. These forward-looking statements speak only as of the date of the development or update of this Web site. Arno disclaims any intent or obligation to update these forward-looking statements.
| Event: | Rodman & Renshaw 10th Annual Healthcare Conference |
| Date: | November 10, 2008 |
| Time: | 2:00 p.m. ET |
| Location: | Presentation: Kennedy I (4th floor)
The New York Palace Hotel, 455 Madison Avenue (at 50th St.), New York, NY 10022 |
|
Web Site: | http://www.rodm.com/conferences?id=19 |
|
|
|
|
|